Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciprofloxacin pharmacokinetics in cachectic elderly patients after intravenous and oral administration
NL-OMON50150Phase 4Active, not recruiting
- Sponsor
- Tergooi MC
- Start
- Nov 2020
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ciprofloxacin in pneumonia, cystitis and urinary tract infection (UTI) (3 arms), sponsored by Tergooi MC. Primary endpoints: Population pharmacokinetic model of ciprofloxacin, Model validation and 1 more. Started Nov 2020; status: active, not recruiting.
02
Drugs
ciprofloxacin
03
Conditions
pneumoniacystitisurinary tract infection (UTI)
Beyond the preview
Go deeper on NL-OMON50150.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON50150.